A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

Chest

Volumn 145, Issue 3, 2014, Pages 639-641

  Whitmore, Timothy J ^a   O'Shea, John P ^c   Starac, Diana ^d   Edwards, Mark G ^b   Waterer, Grant W ^e  

^a Ysbyty Gwynedd   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

^d WESTERN DIAGNOSTIC PATHOLOGY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CLOPIDOGREL; COMPLEMENT; DILTIAZEM; FIBRINOGEN; FLUTICASONE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HEMOGLOBIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; ROSUVASTATIN; SALMETEROL; TICAGRELOR;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTIVE SURGERY; HEMOPTYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CONGESTION; LUNG FIBROSIS; LUNG LAVAGE; MALE; MIDDLE AGED; MONOTHERAPY; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE;

ACUTE CORONARY SYNDROME; ADENOSINE; ASPIRIN; BIOPSY; CORONARY ARTERY BYPASS; DIAGNOSIS, DIFFERENTIAL; HEMOPTYSIS; HUMANS; LUNG; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PNEUMONIA; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896774028     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1502     Document Type: Article

References (14)

1. Stefanini GG , Holmes DR Jr . Drug-eluting coronary-artery stents . N Engl J Med . 2013 ; 368 (3): 254-265 .
2. Juneja S , Gupta K , Kaushal S . Ticagrelor: An emerging oral antiplatelet agent . J Pharmacol Pharmacother . 2013 ; 4 (1): 78-80 .
3. Wallentin L , Becker RC , Budaj A , et al ; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes . N Engl J Med . 2009 ; 361 (11): 1045-1057 .
4. Camus PH , Foucher P , Bonniaud PH , Ask K . Drug-induced infi ltrative lung disease . Eur Respir J Suppl . 2001; 32: 93s- 100s.
5. Storey RF , Becker RC , Harrington RA , et al . Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes . Eur Heart J . 2011 ; 32 (23): 2945-2953 .
6. Storey RF , Bliden KP , Patil SB , et al ; ONSET/OFFSET Investigators . Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery dis ease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study . J Am Coll Cardiol . 2010; 56(3): 185-193.
7. Lange RA , Hillis LD . The duel between dual antiplatelet therapies . N Engl J Med . 2013 ; 368 (14): 1356-1357 .
8. Ohman J , Kudira R , Albinsson S , Olde B , Erlinge D . Ticagrelor induces adenosine triphosphate release from human red blood cells . Biochem Biophys Res Commun . 2012 ; 418 (4): 754-758 .
9. Roy P , Bonello L , Torguson R , et al . Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation . Am J Cardiol . 2008 ; 102 (12): 1614-1617 .
10. Yusuf S , Zhao F , Mehta SR , Chrolavicius S , Tognoni G , Fox KK ; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation . N Engl J Med . 2001 ; 345 (7): 494-502 .
11. Ikeda M , Tanaka H , Sadamatsu K . Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome . Cardiovasc Revasc Med . 2011; 12(6): 407-411.
12. Ishida R , Nomura T , Kojima A , et al . Pulmonary hemorrhage in a middle-aged woman as a complication of treatments for acute myocardial infarction . Journal of Cardiology Cases . 2010; 1 (1): e37-e41 .
13. Iskandar SB , Kasasbeh ES , Mechleb BK , et al . Alveolar hemorrhage: An underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors . J Interv Cardiol . 2006; 19(4): 356-363.
14. Serebruany VL . Viewpoint: reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel . Thromb Haemost . 2012 ; 108 (6): 1024-1027 .